Approval · Notice of Compliance 25907 · 2021
ANDROCUR: Notice of Compliance 25907
Issued May 19, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25907
- Date
- May 19, 2021
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updte to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDROCUR | Not yet assigned | — |
| ANDROCUR DEPOT | Not yet assigned | — |
Medicinal ingredients
- CYPROTERONE ACETATE 50 MG per TAB
- CYPROTERONE ACETATE 100 MG per ML